Sun Pharma to Buy Organon for 11.75 Billion Dollars
Sun Pharmaceutical Industries announced on Sunday that it will acquire U.S. drugmaker Organon for approximately 11.75 billion dollars in an all-cash transaction.
Xurve View
Insights:
Xurve View
SUN CORP has reached a definitive agreement to acquire ORGANON & CO in a transaction valued at approximately $11.75 billion. The all-cash deal marks a significant expansion for the Indian pharmaceutical giant into the United States market and broader global healthcare sectors.
